Navigation Links
Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
Date:5/2/2011

patents to be issued during 2011.  At present, Silence's global patent portfolio contains issued patents and pending applications covering strategic areas of RNAi therapeutic development including multiple proprietary siRNA delivery technologies, potent siRNA sequences specific for high-value disease targets and key RNAi sequence and chemical modifications.

Notes for editors

About Silence Therapeutics plc (www.silence-therapeutics.com)

Silence Therapeutics plc (AIM: SLN) is a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases.  The company possesses multiple proprietary short interfering RNA (siRNA) delivery technology platforms including AtuPLEX, a system that enables the functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake. Additionally, the company has a platform of novel siRNA molecules, AtuRNAi, which provide a number of advantages over conventional siRNA molecules, including reduced cytokine induction and decreased manufacturing costs.  Silence's unique RNAi assets also include structural features for a next generation of RNAi molecules and additional proprietary siRNA sequences against more than 50 highly valued oncology and other disease targets.

The Company's lead internal drug candidate is Atu027, a liposomal AtuRNAi formulation in clinical development for systemic cancer indications and one of the most clinically advanced RNAi therapeutics in the area of oncology. Silence is currently conducting an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid tumors involving single, as well as, repeated intravenous administration. The study is expected to be compl
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Silence Therapeutics Lead RNA Interference Therapeutic Prevents Spread of Cancer to Lungs
2. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
3. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
4. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
5. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
6. Silence Therapeutics Appoints New Vice President of Research
7. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
8. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
9. Cell Therapeutics Retires 7.5% Convertible Senior Notes
10. Talecris Biotherapeutics Announces First Quarter 2011 Results
11. Nektar Therapeutics Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... on technologies and applications. The report starts with ... estimation of markets. Technologies include array comparative genomic ...
(Date:9/2/2015)... , September 2, 2015 Biovista ... winners of the 2015 BeHEARD science challenge, a global ... rare disease researchers, access to the latest life science ... drug repositioning and pathway analytics capability to support ... Foundation in the study of Niemann-Pick Disease Type A ...
(Date:9/2/2015)... 2, 2015 Veracyte, Inc. (NASDAQ: VCYT ... president and chief executive officer, will present at the ... 2015 at 10:30 a.m. ET in New ... audio webcast and subsequent replay may be accessed by ... available shortly after conclusion of the presentation and archived ...
(Date:9/2/2015)... ... 02, 2015 , ... Whitehouse Laboratories is excited to announce ... Resources upcoming educational seminar and training session on Extractable & Leachable testing. Featuring ... provide Updates & Case Studies on the Latest Compliance Implications of USP and ...
Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3
... DATATRAK International, Inc. (OTCQX: DATA), a technology and ... the clinical trials industry, today announced the addition ... Connect Partner Program.  The DATATRAK software suite complements ... processes using state-of-the-art clinical trial technology. ...
... TAIPEI, Taiwan, June 14, 2011 /PRNewswire-Asia/ -- TWi ... enrolled over 50% of the total 240 patients ... for the treatment of Type II Diabetes. The ... designed to evaluate the glycated hemoglglobin A1c (HbA1c) ...
... Twenty-two of America,s most promising scientists have been ... by The Pew Charitable Trusts.  The 2011 Pew Scholars ... recipients of the Albert Lasker Medical Research Award and ... of Scholars is related to many human diseases ranging ...
Cached Biology Technology:Research Dynamics Becomes DATATRAK Connect Partner 2Research Dynamics Becomes DATATRAK Connect Partner 3Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes 222 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences 222 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences 322 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences 4
(Date:9/2/2015)... Security of data and assets has ... organizations, telecommunications, hospitals, as well as individuals. Keys, ... used to prevent unauthorised access. Technological advancements resulted ... could gain access to secure premises after being ... devices and numeric codes. However, hackers also could ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015  Automation ... travelers during airport passenger screening. This is the ... passenger screening process will become unintrusive. An assortment ... based on voluntary background investigations will transform the ... Frost & Sullivan, Global Airport Passenger Screening ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Saudi Arabia Biomedical Sensors Market - Growth, Trends & ... The Saudi Arabia Biomedical Sensors market is estimated ... 3.64% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2
... in medicine. In the future, new tissue grown in a ... the place of damaged cells in the brain. Rather than ... and complicated scientific issues, scientists have been looking to adult ... stem cells are now being cultivated from various tissues in ...
... many serious diseases remain a mystery? In considering that ... School of Medicine has come up with a unified molecular ... may provide an answer. Reviewing findings from multiple ... and Molecular Medicine and Investigator with the Howard Hughes Medical ...
... Texas University of Texas Medical Branch at Galveston researchers ... which the Ebola Zaire virus infects cells a critical ... produced by the virus. Ebola produces severe and often ... close to 90 percent in some outbreaks. No vaccine or ...
Cached Biology News:Tel Aviv University researchers create new stem cell screening tool 2Do 68 molecules hold the key to understanding disease? 2Scientists uncover Ebola cell-invasion strategy 2
... use of small interfering RNA (siRNA) molecules ... interference (RNAi) pathway have generated tremendous interest ... siRNA for experimental use can be synthesized ... then transfected into the target cells in ...
... 12™ is an automated hybridization system for ... automates both the hybridization and post hybridization ... A single instrument can process up to ... and has multi-protocol software, enabling the user ...
... Uncover the biological data hidden in your samples ... manufacturing allows you to create your own microarray ... at your own pace and receive delivery of ... eArray is a secure, online array creation application ...
... the demands of the routine trace metal ... reliable, robust and simple to use instrumentation. ... the most challenging sample matrices found in ... to the toughest analytical challenges found in ...
Biology Products: